Developing the 5-minute point-of-care PCR test: A technology revolutionising molecular diagnostics

With the challenges faced at the peak of the COVID-19 pandemic still very fresh in the memory, delivering point-of-care testing with speed, convenience, and reliability remains a pressing need in primary care. A resurgence in other respiratory pathogens, including influenza A and B, has left no respite for urgent care centers, general practice, and pharmacies as their testing services remain under pressure. The development and implementation of a PCR platform that could produce results in just minutes rather than hours would therefore be transformative.

In this SelectScience^® webinar, Andrew Anyakwo, Head of Reagent Development at LEX Diagnostics, will give a unique insight into how they have been able to achieve just that - developing a low-cost, point-of-care PCR test that aims to diagnose SARS-CoV-2 and Flu A/B in just 5 minutes with high sensitivity and specificity.

Key learning objectives

• Understand the challenges the rapid development of assays/devices presents, how they can be overcome, and what can be learned in the process
• Gain insight into how to deal with inhibitors
• Explore the benefits of partnering with a manufacturer to develop a solution with GMP at scale
• Discover how PCR can be improved upon to revolutionise point-of-care molecular diagnostics

Who should attend?

Assay developers and scientists working within the molecular diagnostics field.

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.